Fatal pneumonia caused by Burkholderia cepacia 9 months after resection of aspergilloma

被引:6
作者
Ishizuka, T
Oyama, T
Sato, M
Hisada, T
Takagi, H
Hamada, T
Kimura, T
Kashiwabara, K
Mori, M
机构
[1] Gunma Univ, Sch Med, Dept Internal Med 1, Maebashi, Gumma 3718511, Japan
[2] Gunma Univ, Sch Med, Dept Lab Med, Maebashi, Gumma 3718511, Japan
[3] Gunma Univ, Sch Med, Div Diagnost Pathol, Maebashi, Gumma 3718511, Japan
关键词
aspergilloma; Aspergillus fumigatus; Burkholderia cepacia; pneumonia; respiratory failure;
D O I
10.1046/j.1440-1843.2003.00476.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
A 69-year-old man developed an episode of severe community-acquired pneumonia 9 months after resection of aspergilloma. Although Aspergillus fumigatus was also isolated in the pleural cavity, it did not invade the remaining lung parenchyma. The patient developed progressive bilateral pneumonia leading to death from respiratory failure. Burkholderia cepacia was considered as prime pathogen, as it was repeatedly cultured from sputum and tracheal secretions, as well as the autopsy lung. B. cepacia is resistant to most antibiotics, and seldom causes pneumonia in patients without cystic fibrosis or chronic granulomatous disease. The precise reason that this apparently immunocompetent patient developed B. cepacia pneumonia remains unknown.
引用
收藏
页码:401 / 403
页数:3
相关论文
共 15 条
[1]   OUTER-MEMBRANE PERMEABILITY IN PSEUDOMONAS-CEPACIA - DIMINISHED PORIN CONTENT IN A BETA-LACTAM-RESISTANT MUTANT AND IN RESISTANT CYSTIC-FIBROSIS ISOLATES [J].
ARONOFF, SC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1636-1639
[2]   Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis [J].
Bonacorsi, S ;
Fitoussi, F ;
Lhopital, S ;
Bingen, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :213-217
[3]   Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance [J].
Burns, JL ;
Wadsworth, CD ;
Barry, JJ ;
Goodall, CP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :307-313
[4]  
Editorial, 1992, LANCET, V339, P1385
[5]   MICROBIOLOGY OF LUNG INFECTION IN CYSTIC-FIBROSIS [J].
GOVAN, JRW ;
NELSON, JW .
BRITISH MEDICAL BULLETIN, 1992, 48 (04) :912-930
[6]   Burkholderia cepacia: Medical, taxonomic and ecological issues [J].
Govan, JRW ;
Hughes, JE ;
Vandamme, P .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 45 (06) :395-407
[7]  
GREGORY WJ, 1986, INFECT CONT HOSP EP, V7, P281
[8]   An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis [J].
Holmes, A ;
Nolan, R ;
Taylor, R ;
Finley, R ;
Riley, M ;
Jiang, RZ ;
Steinbach, S ;
Goldstein, R .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) :1197-1205
[9]   PSEUDOMONAS CEPACIA INFECTION IN CYSTIC-FIBROSIS - AN EMERGING PROBLEM [J].
ISLES, A ;
MACLUSKY, I ;
COREY, M ;
GOLD, R ;
PROBER, C ;
FLEMING, P ;
LEVISON, H .
JOURNAL OF PEDIATRICS, 1984, 104 (02) :206-210
[10]   INCIDENCE, SEVERITY, AND PREVENTION OF INFECTIONS IN CHRONIC GRANULOMATOUS-DISEASE [J].
MOUY, R ;
FISCHER, A ;
VILMER, E ;
SEGER, R ;
GRISCELLI, C .
JOURNAL OF PEDIATRICS, 1989, 114 (04) :555-560